Humanigen Announces Revised Time for Presentation at Jefferies London Healthcare Conference

BURLINGAME, Calif.--(BUSINESS WIRE)--Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,’ announced that its presentation time at the Jefferies London Healthcare Conference has been changed. Jefferies London Healthcare Conference Timothy Morris, COO and CFO, will now make a corporate...

Click to view original post